Clincosm LogoSign in Get a demo

Quality of Life Following Radical Prostatectomy

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT00373308
Collaborator
(none)
888
Enrollment
1
Location
219.8
Duration (Months)
4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will utilize the Expanded Prostate Cancer Index Composite questionnaire to learn what impact the surgery has upon the participant's sense of health, sexual and urinary quality of life.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To define impact on quality of life issues for patients undergoing radical prostatectomy. This study will distribute a questionnaire to patients who are being scheduled for radical prostatectomy, both before and after surgery, to assess the impact on quality of life issues. This will provide important information regarding the temporal return of issues pertaining to quality of life.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    888 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Quality of Life Following Radical Prostatectomy
    Study Start Date :
    Sep 1, 2002
    Actual Primary Completion Date :
    Dec 25, 2020
    Actual Study Completion Date :
    Dec 25, 2020

    Outcome Measures

    Primary Outcome Measures

    1. urinary and bowel habits [before and after surgery]

    2. sexual and hormonal index as self-reported in the questionnaires [before and after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients scheduled to undergo radical prostatectomy at Stanford
    Exclusion Criteria:
    • Patients treated with neoadjuvant or adjuvant hormonal therapy or radiation therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University School of Medicine Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University

    Investigators

    • Principal Investigator: Benjamin I Chung, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stanford University
    ClinicalTrials.gov Identifier:
    NCT00373308
    Other Study ID Numbers:
    • PROS0012
    • 78463
    • PROS0012
    First Posted:
    Sep 8, 2006
    Last Update Posted:
    Aug 5, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Stanford University
    Quality of Life
    Additional relevant MeSH terms:
    Prostatic Neoplasms

    Study Results

    No Results Posted as of Aug 5, 2021